Claritas Pharmaceuticals Inc V.CLAS.H

RE:RE:RE:Can anyone on here compare kly to another MM company

[Thefinals23]

Thefinals23 wrote: Some figures to help out those who say this is worth nothing If I remember right the report* said $400 exclusive market year one and adding $100 million per year to 2027 where it is estimated to be $1.3 billion. As we're not in year 1 since we have no drug - yet, I moved it to 2020 as year one with, the advance in market going up as per the rationale of the report. (All figures in USD not CD unless specified) You can adjust the start time or years with completion but I'm just trying to show what kind of money we're talking about here. 2018 2019 2020 $ 600,000,000 2021 $ 700,000,000 2022 $ 800,000,000 2023 $ 900,000,000 2024 $1,000,000,000 2025 $1,100,000,000 2026 $1,200,000,000 2027 $1,300,000,000 Total $7,600,000,000 ($10,133,000,000 CD) over 8 years or $1.4 billion($1.86 CD) per year average. I'm no rocket scientist but with an exclusive market like that and present shares outstanding of 304 million at cap of $18 million, assuming fifty percent profit brings us to a profit of $12.5 per share ($16.6 CD) over that period. Or, if it's 75% profit then share profit is $18.75 ($25 CD) Average over 8 years and it's $2.34 ($3.12 CD) per share.